Search clinical trials for: BOS-356

Total 4061 results

Bristol-Myers Squibb

Completed

A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)

Tumors

United States
Bristol-Myers Squibb

Completed

Safety Study of BMS-770767 in Subjects With Hypercholesterolemia

Dyslipidemia

Canada, Australia, United States
Bristol-Myers Squibb

Completed

Safety Study to Evaluate BMS-830216 in Healthy Subjects

Obesity

United States
Bristol-Myers Squibb

Completed

Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan

Neoplasms

Japan
Fudan University
Inner Mongolia Yili Industrial Group Co., Ltd

Recruiting

The Effect of Intervention With Probiotic K56 on Body Fat Reduction in Obese Subjects

Obesity

China
Click Therapeutics, Inc.
Boehringer Ingelheim

Completed

A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia

Schizophrenia

United States
Boehringer Ingelheim

Completed

BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
Celgene

Recruiting

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Beta-thalassemia | Myelodysplastic Syndromes (MDS) | Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis

United States, Japan, Israel, United Kingdom, Turkey, Greece, Netherlands, France, Australia, Belgium, Bulgaria, Canada, Germany, Italy, Malaysia, Spain, Sweden, Taiwan, Thailand, Tunisia, China, Lebanon
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute

Not yet recruiting

Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults

Intestinal Health

United States
Institute of Psychology, Chinese Academy of Sciences

Completed

Young People Aged 18-25 With Depression or Anxiety Mood Participate in an LLM-based Digital Dialogue Intervention Study

Depression | Anxiety | LLM-based AI Dialogue Bot

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
Bristol-Myers Squibb

Terminated

Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors

Neuroendocrine Tumors | Carcinoid Tumor

United States
John Kirkwood
Bristol-Myers Squibb

Active, not recruiting

Nivolumab, BMS-936558 in Combination With Relatlimab, BMS-986016 in Patients With Metastatic Melanoma Naïve to Prior Immunotherapy in the Metastatic Setting

Melanoma

United States
Bristol-Myers Squibb

Completed

Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors

Cancer

Australia, United States, Canada
Bristol-Myers Squibb

Completed

Single Ascending Dose (BMS-813160) Study

Accelerated Intimal Hyperplasia

United States
Cambridge University Hospitals NHS Foundation Trust
King's College London

Completed

Pilot Randomized Controlled Trial of a Breathlessness Intervention Service for Chronic Obstructive Pulmonary Disease (BIS-PhIInm)

Dyspnea

United Kingdom
South Valley University

Active, not recruiting

Determinants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRS

Health Related Quality of Life

Egypt
Institute of Medical Biology, Chinese Academy of...
Guangxi Center for Disease Control and Prevention

Completed

A Protected Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants and Children

The Efficacy of Inactivated EV71 Vaccine (KMB17) Against HFMD in Chinese Children and Infants

China
Medical University of Warsaw
Polish Academy of Sciences; University of Warsaw

Completed

The Effect of Bicarbonate Profiling in Dialysis Fluid on Phosphate Removal During Hemodialysis and Blood pH

Phosphorus Metabolism Disorders | Acid-Base Balance Disorder

Poland
Centre Cardiologique du Nord

Not yet recruiting

Anaesthetic Depth and Short Term Delirium Post Cardiac Surgery Intervention (BISCAR)

Post-operative Delirium | Anaesthetic Depth

France
Antibe Therapeutics Inc.
Veristat, Inc.

Completed

Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis Patients

Osteoarthritis

Canada
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia

Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Biphenotypic Leukemia

United States
Lesaffre International

Completed

Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype (IBS-GO)

Constipation-predominant Irritable Bowel Syndrome

France
Kaiser Permanente
TaiMed Biologics Inc.

Completed

Investigator-Sponsored Protocol - Continued Use of Ibalizumab

HIV Infections

United States
Istinye University

Completed

Sleep Quality of Physiotherapy Students Quality of Life and Physical Activity Level (SleepQuality)

Quality of Life | Physical Activity | Sleep Quality

Turkey
Azienda USL Toscana Nord Ovest
Istituto per la Ricerca e l'Innovazione Biomedica

Not yet recruiting

Objective Measurement of Pain in Individuals With Cognitive Deterioration Utilizing Electroencephalography

Cognitive Deterioration

Italy
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants

Healthy Participants

United Kingdom
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Biological Therapy. (SASAB)

Asthma | Small Airway Disease

Italy
Helsinki University Central Hospital
DexCom, Inc.

Not yet recruiting

Happy Bob App in 9-13 Year-old Children

Type1diabetes
Centre Hospitalier Universitaire de Besancon

Recruiting

3D Personalized Modelization of the Hand Using EOS Imaging System (M3DME)

Hand Injuries

France
Bristol-Myers Squibb

Active, not recruiting

A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis

Psoriasis

United States, Australia, Canada, Japan, United Kingdom
Bristol-Myers Squibb

Completed

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants

Healthy Volunteers

United States
Bristol-Myers Squibb

Terminated

A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants

Healthy Participants

United States
Abbott Medical Devices

Completed

Absorb GT1 Japan PMS

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery Occlusion

Japan
Leiden University Medical Center

Completed

The Box 2.0: Using Smart Technology for Early Diagnosis of Complications After Cardiovascular Surgery

Mobile Health | Rehabilitation After Cardiovascular Surgery

Netherlands
BioLeaders Corporation

Completed

Safety Study of BLS-M22 in Healthy Volunteers

Muscular Dystrophy, Duchenne

Korea, Republic of
Medical School of Tunisia
Institut Kassab d'Orthopédie

Unknown

Performance of EOS Imaging System in the Assessment of Spondyloarthritis Structural Changes Compared With Standard Radiography

Spondyloarthritis

Tunisia
Biogen

Terminated

Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002003

Supranuclear Palsy, Progressive

United States
Massachusetts General Hospital

Completed

Light Therapy as Treatment for Fatigue in Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

United States
Medical University of Silesia
Wojciech Wojakowski

Completed

New-DES vs BMS in SVG -1 Year Outcomes (BALTIC)

Coronary Artery Disease

Poland
Bristol-Myers Squibb

Withdrawn

A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants

Healthy Participants

United States
Bristol-Myers Squibb

Completed

A Study to Test the Effects of BMS-986036 on the Body in Healthy Japanese and Non-Japanese Subjects

Metabolics

United States
Bristol-Myers Squibb

Completed

Safety and Tolerability Study of BMS-986177 in Healthy Subjects

Thrombosis

Belgium
University Health Network, Toronto

Completed

Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome

Basal Cell Nevus Syndrome

Canada
Seattle Children's Hospital

Completed

Evaluation of a Walking School Bus Program

Obesity | Physical Activity

United States
ASLAN Pharmaceuticals

Completed

A Phase I Multiple Ascending Dose Study of ASLAN002 in Subjects With Advanced or Metastatic Solid Tumours

Malignant Solid Tumour
Bristol-Myers Squibb

Completed

Crossover Post-herpetic Neuralgia (PHN)

Post-Herpetic Neuralgia (PHN)

United States, France
Bristol-Myers Squibb

Completed

Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects

Obesity

United States
Bristol-Myers Squibb

Completed

BMS-741672 for Diabetic Neuropathic Pain

Neuropathic Pain

United States
Bristol-Myers Squibb

Completed

A Phase II, Multicenter, Double Blind, Placebo-Controlled Safety, Tolerability Study of BMS-708163 in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Sweden, United States, Denmark, Finland
Bristol-Myers Squibb

Completed

Randomized, Placebo-Controlled, Double-Blind, Ascending Single and Multiple Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-963272 in Healthy Subjects

Healthy

United States

Search clinical trials for: BOS-356

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations